imiquimod has been researched along with Cancer of Cervix in 37 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (5.41) | 18.2507 |
| 2000's | 7 (18.92) | 29.6817 |
| 2010's | 19 (51.35) | 24.3611 |
| 2020's | 9 (24.32) | 2.80 |
| Authors | Studies |
|---|---|
| Aberle, SW; Berger, R; Boehm, I; Bogner, G; Ciresa-Koenig, A; Ganhoer-Schimboeck, J; Gleiss, A; Grimm, C; Hadjari, L; Heinze, G; Joura, E; Langthaler, E; Polterauer, S; Reich, O; Reinthaller, A; Trutnovsky, G; Widschwendter, A | 1 |
| de Vos Van Steenwijk, PJ; Hendriks, N; Hoosemans, L; Koeneman, MM; Kooreman, LFS; Kruitwagen, RFPM; Kruse, AJ; Nijman, HW; Penders, CGJ; Piek, JMJ; Sep, SJS; Slangen, BFM; van Beekhuizen, HJ; van de Sande, AJM; van Kuijk, SMJ | 1 |
| Alvarez-Mendoza, C; Hurt, CN; Jones, S; Nedjai, B; Powell, N; Tristram, A | 1 |
| Bevilacqua, F; Bornstein, J; Carcopino, X; Chargari, C; Cruickshank, M; Erzeneoglu, E; Esat Temiz, B; Gallio, N; Gultekin, M; Heller, D; Joura, E; Kesic, V; Kyrgiou, M; Madić, T; Planchamp, F; Preti, M; Regauer, S; Reich, O; Stockdale, C; Vieira-Baptista, P; Woelber, L; Zodzika, J | 1 |
| Efthimiou, O; Furukawa, TA; Hamanishi, J; Horinouchi, N; Inayama, Y; Kawakami, K; Kosaka, K; Mandai, M; Mizuno, K; Murakami, R; Takamatsu, S; Taki, M; Yamaguchi, K; Yamanoi, K | 1 |
| Bauman, JE; Chow, HS; Desravines, N; House, M; Hsu, CH; Mohnot, S; O'Connor, S; Rahangdale, L; Sahasrabuddhe, V; Sauter, E | 1 |
| Benedetto, C; Bertero, L; Borella, F; Cassoni, P; Gallio, N; Mangherini, L; Preti, M | 1 |
| Beck, RCR; Buffon, A; Chaves, P; Frank, LA; Gazzi, RP; Guterres, SS; Mello, PA; Peña, F; Pohlmann, AR | 1 |
| Accorsi, GS; Antoniazzi, M; Dos Reis, R; Fonseca, BO; Fregnani, JHTG; Matsushita, GM; Pantano, NP; Possati-Resende, JC; Salcedo, MP; Santana, IVV; Schmeler, KM | 1 |
| Gerestein, CG; Koeneman, MM; Kruse, AJ; van Beekhuizen, HJ; van de Sande, AJM; van Kemenade, FJ | 1 |
| Buffon, A; de Andrade Mello, P; Frank, LA; Gazzi, RP; Guterres, SS; Pohlmann, AR | 1 |
| Lopaschuk, CC | 1 |
| Dosekun, O; Farrugia, P; Lewis, F; Sethi, G | 1 |
| Chen, FP | 1 |
| Bechtel, MA; Trout, W | 1 |
| de Witte, CJ; Gerestein, CG; Koeneman, MM; Kruse, AJ; van Beekhuizen, HJ; van de Sande, AJ | 1 |
| Berends-van der Meer, DM; Bosse, T; Daemen, T; Fathers, LM; Fleuren, GJ; Hamming, IL; Hellebrekers, BW; Hollema, H; Kagie, MJ; Kenter, GG; Loof, NM; Löwik, MJ; Melief, CJ; Nijman, HW; Oostendorp, J; Oude Elberink, JH; Schreuder, HW; Stijnen, T; Stynenbosch, LF; Trimbos, JB; Valentijn, AR; van Beurden, M; van der Burg, SH; van Esch, EM; van Poelgeest, MI; Vermeij, R; Welters, MJ | 1 |
| Gerestein, CG; Hopman, AHN; Koeneman, MM; Kooreman, LFS; Kruitwagen, RFPM; Kruse, AJ; Nijman, HW; Sep, SJS; Slangen, BFM; van Beekhuizen, HJ; van de Sande, M; Van Gorp, T; Zur Hausen, A | 1 |
| Loutradis, D; Patta, J; Pergialiotis, V; Stefanidi, D; Stefanidis, K | 1 |
| Barata, SA; Calhaz-Jorge, C; Colaço, AM; Lopes, JP; Policiano, AC | 1 |
| Bissery, MC; Bouillette-Marussig, M; Cools, N; De Coster, I; Depuydt, C; Goossens, H; Goubier, A; Hens, A; Hercend, T; Timmerman, B; Van Damme, P; Van Tendeloo, V | 1 |
| Gerestein, CG; Hopman, AH; Koeneman, MM; Kooreman, LF; Kruitwagen, RF; Kruse, AJ; Nijman, HW; Sep, SJ; Slangen, BF; van Beekhuizen, HJ; van de Sande, AJ; Van Gorp, T; Zur Hausen, A | 1 |
| Da Silva, DM; Fahey, LM; Kast, WM; Raff, AB | 1 |
| Cen, JP; Chen, XZ; Cheng, H; Jin, N; Mao, XH; Ye, J; Zhou, Q; Zhu, KJ | 1 |
| Barton, DL; Clayton, AC; Gostout, BS; Jefferies, JA; Loprinzi, CL; McGovern, RM; Novotny, PJ; Pachman, DR; Sloan, JA | 1 |
| Kaushal, S; Kopparthy, P; Merideth, M; Pulanic, TK; Stratton, P | 1 |
| Grimm, C; Hefler, L; Heinze, G; Natter, C; Polterauer, S; Rahhal, J; Reinthaller, A; Speiser, P; Stary, G; Tempfer, CB | 1 |
| Chang, SD; Chou, HH; Huang, CC; Jao, MS; Jung, SM; Lai, CH; Lin, CT; Qiu, JT; Tang, YH; Wang, CJ; Wu, PJ | 1 |
| Campagne, G; Martínez, A; Roca, M | 1 |
| Belcastro, M; Flynn, DC; Miller, MR; Soisson, AP | 1 |
| Bower, M; Dancey, G; Stebbing, J | 1 |
| Alarcón Romero, Ldel C; Hernández Quijano, T; Hernández Valencia, M; Illanes Aguiar, B; Salas Linares, N | 1 |
| Apgar, BS | 1 |
| Gall, SA | 1 |
| Arany, I; Diaz-Arrastia, C; Dinh, TV; Gatalica, Z; Hannigan, E; Robazetti, SC; Tyring, SK | 1 |
7 review(s) available for imiquimod and Cancer of Cervix
| Article | Year |
|---|---|
The European Society of Gynaecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study of Vulval Disease (ECSVD), and the European Federation for Colposcopy (EFC) consensus state
Topics: Carcinoma in Situ; Colposcopy; Female; Humans; Imiquimod; Papillomavirus Infections; Pregnancy; Quality of Life; Retrospective Studies; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms; Vaginal Neoplasms | 2023 |
Imiquimod for Cervical and Vaginal Intraepithelial Neoplasia: A Systematic Review and Meta-analysis.
Topics: Aminoquinolines; Antineoplastic Agents; Female; Humans; Imiquimod; Prospective Studies; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms | 2023 |
Recent advances in treating female genital human papillomavirus related neoplasms with topical imiquimod.
Topics: Adjuvants, Immunologic; Female; Human Papillomavirus Viruses; Humans; Imiquimod; Papillomaviridae; Papillomavirus Infections; Uterine Cervical Neoplasms; Vagina; Vulvar Neoplasms | 2023 |
New approach to managing genital warts.
Topics: Aminoquinolines; Clinical Protocols; Condylomata Acuminata; Female; Humans; Imiquimod; Papillomavirus Infections; Papillomavirus Vaccines; Podophyllotoxin; Pregnancy; Uterine Cervical Neoplasms | 2013 |
Sexually transmitted diseases.
Topics: Acyclovir; Aminoquinolines; Anti-Bacterial Agents; Antineoplastic Agents; Antiviral Agents; Chancre; Condylomata Acuminata; Female; Herpes Genitalis; Humans; Imiquimod; Papillomavirus Infections; Papillomavirus Vaccines; Penicillins; Podophyllotoxin; Sexually Transmitted Diseases; Syphilis, Cutaneous; Uterine Cervical Neoplasms; Valacyclovir; Valine | 2015 |
Imiquimod in cervical, vaginal and vulvar intraepithelial neoplasia: a review.
Topics: Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Female; Humans; Imiquimod; Papillomavirus Infections; Treatment Outcome; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms; Vaginal Neoplasms; Vulvar Neoplasms | 2015 |
Female genital warts: global trends and treatments.
Topics: Adjuvants, Immunologic; Aminoquinolines; Condylomata Acuminata; Female; Global Health; Health Knowledge, Attitudes, Practice; Humans; Imiquimod; Incidence; Papillomavirus Infections; Prevalence; Risk Factors; Treatment Outcome; Uterine Cervical Neoplasms | 2001 |
11 trial(s) available for imiquimod and Cancer of Cervix
| Article | Year |
|---|---|
Topical imiquimod compared with conization to treat cervical high-grade squamous intraepithelial lesions: Multicenter, randomized controlled trial.
Topics: Colposcopy; Conization; Female; Humans; Imiquimod; Papillomavirus Infections; Pregnancy; Squamous Intraepithelial Lesions; Uterine Cervical Neoplasms | 2022 |
Topical Imiquimod Treatment of High-grade Cervical Intraepithelial Neoplasia (TOPIC-3): A Nonrandomized Multicenter Study.
Topics: Female; Humans; Imiquimod; Male; Treatment Outcome; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms | 2022 |
Combined HPV 16 E2 and L1 methylation predict response to treatment with cidofovir and imiquimod in patients with vulval intraepithelial neoplasia.
Topics: Aminoquinolines; Biomarkers; Cidofovir; DNA Methylation; Female; Human papillomavirus 16; Humans; Imiquimod; Papillomavirus Infections; Prospective Studies; Uterine Cervical Neoplasms; Vulvar Neoplasms | 2022 |
Topical Imiquimod for the Treatment of High-Grade Squamous Intraepithelial Lesions of the Cervix: A Randomized Controlled Trial.
Topics: Administration, Topical; Adult; Antineoplastic Agents; Combined Modality Therapy; Electrosurgery; Female; Humans; Imiquimod; Intention to Treat Analysis; Margins of Excision; Middle Aged; Neoplasm Grading; Papillomavirus Infections; Squamous Intraepithelial Lesions of the Cervix; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms; Young Adult | 2021 |
TOPical Imiquimod treatment of residual or recurrent cervical intraepithelial neoplasia (TOPIC-2 trial): a study protocol for a randomized controlled trial.
Topics: Adult; Antineoplastic Agents; Female; Humans; Imiquimod; Middle Aged; Neoplasm Recurrence, Local; Neoplasm, Residual; Research Design; Single-Blind Method; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms | 2018 |
Vaccination against Oncoproteins of HPV16 for Noninvasive Vulvar/Vaginal Lesions: Lesion Clearance Is Related to the Strength of the T-Cell Response.
Topics: Adult; Aged; Aminoquinolines; Cancer Vaccines; Carcinoma in Situ; CD8-Positive T-Lymphocytes; Female; Human papillomavirus 16; Humans; Imiquimod; Interferon-gamma; Middle Aged; Oncogene Proteins, Viral; Papillomavirus E7 Proteins; Papillomavirus Infections; Papillomavirus Vaccines; Uterine Cervical Neoplasms; Vaccination; Vaginal Neoplasms; Vulvar Neoplasms; Young Adult | 2016 |
TOPical Imiquimod treatment of high-grade Cervical intraepithelial neoplasia (TOPIC trial): study protocol for a randomized controlled trial.
Topics: Administration, Topical; Adult; Aged; Aminoquinolines; Antineoplastic Agents; Drug Administration Schedule; Female; Humans; Imiquimod; Middle Aged; Neoplasm Grading; Pancreatitis-Associated Proteins; Quality of Life; Treatment Outcome; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms; Young Adult | 2016 |
GTL001, A Therapeutic Vaccine for Women Infected with Human Papillomavirus 16 or 18 and Normal Cervical Cytology: Results of a Phase I Clinical Trial.
Topics: Adjuvants, Immunologic; Adolescent; Adult; Aminoquinolines; Cervix Uteri; DNA-Binding Proteins; Double-Blind Method; Female; Human papillomavirus 16; Human papillomavirus 18; Humans; Imiquimod; Middle Aged; Oncogene Proteins, Viral; Papillomavirus E7 Proteins; Papillomavirus Infections; Papillomavirus Vaccines; T-Lymphocytes; Uterine Cervical Neoplasms; Vaccination; Viral Load; Young Adult | 2016 |
Preliminary stop of the TOPical Imiquimod treatment of high-grade Cervical intraepithelial neoplasia (TOPIC) trial.
Topics: Administration, Topical; Aminoquinolines; Antineoplastic Agents, Immunological; Female; Humans; Imiquimod; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms | 2017 |
Randomized clinical trial of imiquimod: an adjunct to treating cervical dysplasia.
Topics: Adult; Aminoquinolines; Antineoplastic Agents; Antiviral Agents; Condylomata Acuminata; Drug Administration Routes; Female; Humans; Imiquimod; Papillomavirus Infections; Severity of Illness Index; Treatment Outcome; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms; Young Adult | 2012 |
Treatment of cervical intraepithelial neoplasia with topical imiquimod: a randomized controlled trial.
Topics: Adult; Aminoquinolines; Antineoplastic Agents; Female; Humans; Imiquimod; Papillomavirus Infections; Remission Induction; Treatment Outcome; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms; Viral Load; Young Adult | 2012 |
19 other study(ies) available for imiquimod and Cancer of Cervix
| Article | Year |
|---|---|
Feasibility of 5-fluorouracil and imiquimod for the topical treatment of cervical intraepithelial neoplasias (CIN) 2/3.
Topics: Adult; Feasibility Studies; Female; Fluorouracil; Humans; Imiquimod; Papillomaviridae; Papillomavirus Infections; Prospective Studies; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms; Young Adult | 2023 |
Anti-HPV Nanoemulsified-Imiquimod: A New and Potent Formulation to Treat Cervical Cancer.
Topics: Animals; Cell Line, Tumor; Drug Compounding; Emulsions; Female; Humans; Imiquimod; Nanoparticles; Papillomaviridae; Swine; Uterine Cervical Neoplasms | 2020 |
Imiquimod-loaded nanocapsules improve cytotoxicity in cervical cancer cell line.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Survival; Cytotoxins; Drug Carriers; Female; Humans; Imiquimod; Nanocapsules; Uterine Cervical Neoplasms | 2019 |
Vulval disease in HIV-positive women attending a tertiary vulval dermatology clinic over a five-year period.
Topics: Adult; Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; CD4 Lymphocyte Count; Female; HIV Infections; Humans; Imiquimod; Middle Aged; Treatment Outcome; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms; Vulvar Diseases | 2013 |
Efficacy of imiquimod 5% cream for persistent human papillomavirus in genital intraepithelial neoplasm.
Topics: Aminoquinolines; Antineoplastic Agents; Cervix Uteri; Chemotherapy, Adjuvant; Female; Follow-Up Studies; Humans; Imiquimod; Neoplasm Recurrence, Local; Papanicolaou Test; Papillomavirus Infections; Retrospective Studies; Severity of Illness Index; Time Factors; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms; Vagina; Vaginal Neoplasms; Vaginal Smears | 2013 |
Imiquimod treatment effectively reduces the percentage of viable cells in a cervical carcinoma cell line but does not affect the expression of HLA-G or OCT-4.
Topics: Aminoquinolines; Cell Survival; Female; Gene Expression Regulation, Neoplastic; HeLa Cells; HLA-G Antigens; Humans; Imiquimod; Octamer Transcription Factor-3; Toll-Like Receptor 7; Uterine Cervical Neoplasms | 2015 |
Topical Therapy With Imiquimod for Vaginal Intraepithelial Neoplasia: A Case Series.
Topics: Adult; Aminoquinolines; Antineoplastic Agents; Female; Humans; Imiquimod; Middle Aged; Treatment Outcome; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms; Vagina | 2016 |
Reversal of human papillomavirus-specific T cell immune suppression through TLR agonist treatment of Langerhans cells exposed to human papillomavirus type 16.
Topics: Adjuvants, Immunologic; Aminoquinolines; Antineoplastic Agents; Cells, Cultured; Epitopes, T-Lymphocyte; Female; Human papillomavirus 16; Humans; Imidazoles; Imiquimod; Immunity, Cellular; Immunosuppressive Agents; Langerhans Cells; Papillomavirus Infections; Quinolines; T-Lymphocytes; Toll-Like Receptor 7; Toll-Like Receptor 8; Uterine Cervical Neoplasms | 2009 |
Toll like receptor agonists augment HPV 11 E7-specific T cell responses by modulating monocyte-derived dendritic cells.
Topics: Aminoquinolines; Antigen Presentation; Cell Differentiation; Cells, Cultured; Colonic Neoplasms; Condylomata Acuminata; Cytotoxicity, Immunologic; Dendritic Cells; Epitopes, T-Lymphocyte; Female; HLA-A Antigens; HLA-A2 Antigen; Human papillomavirus 11; Humans; Imiquimod; Interferon-gamma; Lipopolysaccharides; Lymphocyte Activation; Monocytes; Oligonucleotides; Oncogene Proteins, Viral; Poly I-C; Th1 Cells; Toll-Like Receptors; Tumor Virus Infections; Uterine Cervical Neoplasms; Viral Vaccines | 2010 |
Treatment of multifocal Bowen's disease in immunocompromised women with surgery and topical imiquimod.
Topics: Adult; Aminoquinolines; Antineoplastic Agents; Bowen's Disease; Female; HIV Infections; Humans; Imiquimod; Immunocompromised Host; Skin Neoplasms; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms; Vulvar Neoplasms | 2012 |
[Item 149--Epithelial and melanotic skin tumors: human papillomavirus (HPV) tumors].
Topics: Adult; Alphapapillomavirus; Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; Child; Combined Modality Therapy; Condylomata Acuminata; Cryosurgery; Cryotherapy; Female; Gammapapillomavirus; Humans; Imiquimod; Immunocompromised Host; Laser Therapy; Lasers, Gas; Male; Papillomavirus Infections; Papillomavirus Vaccines; Podophyllotoxin; Pregnancy; Pregnancy Complications, Neoplastic; Risk; Skin Neoplasms; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms; Vaccination; Warts | 2012 |
Topical imiquimod treatment for human papillomavirus infection in patients with and without cervical/vaginal intraepithelial neoplasia.
Topics: Adjuvants, Immunologic; Administration, Topical; Adult; Aged; Aged, 80 and over; Aminoquinolines; Carcinoma in Situ; DNA, Viral; Female; Humans; Imiquimod; Middle Aged; Papillomaviridae; Papillomavirus Infections; Retrospective Studies; Uterine Cervical Neoplasms; Vaginal Neoplasms | 2012 |
Successful treatment of a high-grade intraepithelial neoplasia with imiquimod, with vulvar pemphigus as a side effect.
Topics: Adjuvants, Immunologic; Adult; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Carcinoma, Squamous Cell; Female; Genital Neoplasms, Female; Humans; Imiquimod; Papillomaviridae; Papillomavirus Infections; Pemphigus; Treatment Outcome; Uterine Cervical Neoplasms; Vaginal Neoplasms; Vulvar Diseases; Vulvar Neoplasms | 2003 |
C/EBPbeta activity and HPV-16 E6/E7 mRNA expression are not altered by imiquimod (ALDARA) in human cervical cancer cells in vitro.
Topics: Aminoquinolines; Antineoplastic Agents; CCAAT-Enhancer-Binding Protein-beta; DNA, Viral; Female; Gene Expression Regulation, Viral; HeLa Cells; Humans; Imiquimod; Oncogene Proteins, Viral; Papillomaviridae; Papillomavirus E7 Proteins; Papillomavirus Infections; Repressor Proteins; RNA, Messenger; Tumor Virus Infections; Uterine Cervical Neoplasms | 2004 |
A tale of three Hs: HPV, HIV & HAART.
Topics: Aminoquinolines; Antineoplastic Agents; Antiretroviral Therapy, Highly Active; Anus Neoplasms; Female; HIV Infections; Humans; Imiquimod; Male; Mass Screening; Papillomaviridae; Papillomavirus Infections; Uterine Cervical Neoplasms; Viral Vaccines | 2006 |
[Assessment of the treatment with imiquimod in persistent infection by human papillomavirus with the polimerase chain reaction method].
Topics: Adjuvants, Immunologic; Adult; Aminoquinolines; Female; Humans; Imiquimod; Papillomaviridae; Papillomavirus Infections; Polymerase Chain Reaction; Uterine Cervical Neoplasms | 2006 |
Changes in strategies for human papillomavirus genital disease.
Topics: Aminoquinolines; Colposcopy; DNA, Viral; Female; Genital Diseases, Female; Humans; Imiquimod; Interferon Inducers; Papillomaviridae; Papillomavirus Infections; Risk Factors; Tumor Virus Infections; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms | 1997 |
Imiquimod for genital warts.
Topics: Aminoquinolines; Condylomata Acuminata; Dose-Response Relationship, Drug; Fees, Pharmaceutical; Female; Humans; Imiquimod; Interferon Inducers; Skin Absorption; Uterine Cervical Neoplasms | 1997 |
Clinical and molecular responses in high-grade intraepithelial neoplasia treated with topical imiquimod 5%.
Topics: 2',5'-Oligoadenylate Synthetase; Administration, Topical; Adult; Aminoquinolines; Antineoplastic Agents; Female; Follow-Up Studies; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Genital Neoplasms, Female; Humans; Imiquimod; Middle Aged; Ointments; RNA, Neoplasm; Time Factors; Treatment Outcome; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms; Vaginal Neoplasms; Vulvar Neoplasms | 2001 |